Skip to main content

Peer Review reports

From: Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized, phase IIIb OCTAVE study

Original Submission
28 Feb 2019 Submitted Original manuscript
10 Apr 2019 Author responded Author comments - Giovanni Staurenghi
Resubmission - Version 2
10 Apr 2019 Submitted Manuscript version 2
4 Jun 2019 Reviewed Reviewer Report - Jennifer Arnold
20 Jun 2019 Reviewed Reviewer Report - Focke Ziemssen
4 Sep 2019 Author responded Author comments - Giovanni Staurenghi
Resubmission - Version 3
4 Sep 2019 Submitted Manuscript version 3
23 Sep 2019 Reviewed Reviewer Report - Jennifer Arnold
2 Oct 2019 Reviewed Reviewer Report - Focke Ziemssen
10 Nov 2019 Author responded Author comments - Giovanni Staurenghi
Resubmission - Version 4
10 Nov 2019 Submitted Manuscript version 4
20 Nov 2019 Author responded Author comments - Giovanni Staurenghi
Resubmission - Version 5
20 Nov 2019 Submitted Manuscript version 5
Publishing
21 Nov 2019 Editorially accepted
9 Jan 2020 Article published 10.1186/s12886-019-1251-6

You can find further information about peer review here.

Back to article page